The relationship between non-acute adolescent cannabis use and cognition

Drug and Alcohol Review

Volumn 26, Issue 3, 2007, Pages 309-319

  Harvey, Megan A ^a,b   Sellman, John D ^a   Porter, Richard J ^a   Frampton, Christopher M ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b National Addiction Centre   (New Zealand)

Author keywords

Adolescents; Cannabis; Cognition; Predictor variables; Working memory

Indexed keywords

TETRAHYDROCANNABINOL;

ADDICTION; ADOLESCENT; ARTICLE; ATTENTION; CANNABIS ADDICTION; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; COMORBIDITY; DRUG EFFECT; FEMALE; HUMAN; LEARNING; MALE; NEUROPSYCHOLOGICAL TEST; NEW ZEALAND; ORIENTATION; PSYCHOLOGICAL ASPECT; SHORT TERM MEMORY; SUBSTANCE ABUSE; URINE; WECHSLER INTELLIGENCE SCALE;

ADOLESCENT; ATTENTION; COGNITION DISORDERS; COMORBIDITY; FEMALE; HUMANS; LEARNING; MALE; MARIJUANA ABUSE; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; NEW ZEALAND; ORIENTATION; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; TETRAHYDROCANNABINOL; WECHSLER SCALES;

EID: 34147179619     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230701247772     Document Type: Article

References (51)

1. Wilkins C, Casswell S, Bhatta K, Pledger M. Drug use in New Zealand: National surveys comparison 1998 & 2001. Auckland: Alcohol & Public Health Research Unit, University of Auckland, 2002.
2. Fergusson D, Horwood J. Cannabis use and dependence in a New Zealand birth cohort. NZ Med J 2000;113:156-8.
3. Poulton R, Brooke M, Moffitt T, Stanton W, Silva P. Prevalence and correlates of cannabis use and dependence in young New Zealanders. NZ Med J 1997;110:68-70.
4. Adamson S, Sellman D, Futterman-Collier A, Huriwai T, Deering D, Todd F, Robertson P. A profile of alcohol and drug clients in New Zealand: results from the 1998 National Telephone Survey. NZ Med J 2000;113:414-6.
5. Pope HG Jr, Gruber A, Yurgelun-Todd D. The residual neuropsychological effects of cannabis: the current status of research. Drug Alcohol Depend 1995;38:25-34.
6. Pope HG Jr, Gruber AJ, Yurgelun-Todd D. Residual neuropsychologic effects of cannabis. Curr Psychiatry Rep 2001;3:507-12.
7. Pope HG Jr. Cannabis, cognition and residual confounding. J Am Med Ass 2002;287:1172-4.
8. Pope H Jr, Gruber A, Hudson J, Huestis M, Yurgelun-Todd D. Cognitive measures in long-term cannabis users. J Clin Pharmacol 2002;42:41s-7s.
9. Pope H Jr, Jacobs A, Mialet J, Yurgelun-Todd D, Gruber S. Evidence for a sex-specific residual effect of cannabis on visuospatial memory. Psychother Psychosom 1997;66:179-84.
10. Pope H Jr, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. J Am Med Ass 1996;275:521-7.
11. Block R, Farnham S, Braverman K, Noyes R, Ghoneim M. Long-term marijuana use and subsequent effects on learning and cognitive functions related to school achievement: Preliminary study. In: Spencer JW, Boren JJ, eds. Residual effects of abuse drugs on behavior. Rockville: National Institute on Drug Abuse, 1990:96-111.
12. Block R, Ghoneim M. Effects of chronic marijuana use on human cognition. Psychopharmacology 1993;110:219-28.
13. Solowij N. Cannabis and cognitive functioning. International research monographs in the addictions. Cambridge, England: Cambridge University Press, 1998.
14. Solowij N, Stephens R, Roffman R, Babor T, Kadden R, Miller M, Christiansen K, McRee B, Vendetti J. Cognitive functioning of long-term heavy cannabis users seeking treatment. J Am Med Ass 2002;287:1123-31.
15. Giancola P, Shoal G, Mezzich A. Constructive thinking, executive functioning, antisocial behaviour, and drug use involvement in adolescent females with a substance use disorder. Exp Clin Psychopharmacol 2001;9:215-27.
16. Teichner G, Donohue B, Crum T, Azrin N, Golden C. The relationship of neuropsychological functioning to measures of substance use in an adolescent drug abusing sample. Int J Neurosci 2000;104:113-24.
17. Tapert S, Granholm E, Leedy N, Brown S. Substance use and withdrawal: Neuropsychological functioning over 8 years in youth. J Int Neuropsycholog Soc 2002;8:873-83.
18. Lynskey M, Coffey C, Degenhardt L, Carlin J, Patton G. A longitudinal study of the effects of adolescent cannabis use on high school completion. Addiction 2003;98:685-92.
19. Fergusson D, Horwood J, Beautrais A. Cannabis and educational achievement. Addiction 2003;98;1681-92.
20. Schwartz R, Gruenewald P, Klitzner M, Fedio P. Short-term memory impairments in cannabis-dependent adolescents. Am J Dis Children 1989;143:1214-19.
21. Porter R, Gallagher P, Thompson J, Young A. Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry 2003;182:214-20.
22. Stordal K, Lundervold A, Egeland J, Mykletun A, Asbjørnsen A, Landrø N, Roness A, Rund B, Sundet K, Oedegaard K, Lund A. Impairment across executive functions in recurrent major depression. Nordic J Psychiatry 2004;58:41-7.
23. Barnett R, Maruff P, Vance A, Luk E, Costin J, Wood C, Pantelis C. Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory. Psycholog Med 2001;31:1107-15.
24. Oosterlaan J, Scheres A, Sergeant J. Which executive functioning deficits are associated with AD/HD, ODD/CD and comorbid AD/HD + ODD/CD? J Abnormal Child Psychol 2005;33:69-85.
25. Speltz M, DeKlyen M, Calderon R, Greenberg M, Fisher P. Neuropsychological characteristics and test behaviours of boys with early onset conduct problems. J Abnormal Psychol 1999;108:315-25.
26. Lowe P, Mayfield J, Reynolds C. Gender differences in memory test performance among children and adolescents. Arch Clin Neuropsychol 2003;18:865-78.
27. Kaufman A, McLean J, Reynolds C. Sex, race, residence, region, and education differences on the 11 WAIS-R subtests. J Clin Psychol 1988;44:231-47.
28. Townshend J, Duka T. Binge drinking, cognitive performance and mood in a population of young social drinkers. Alcohol Clin Exp Res 2005;29:317-25.
29. Brown S, Tapert S, Granholm E, Delis D. Neurocognitive functioning of adolescents: Effects of protracted alcohol use. Alcoholism Clin Exp Res 2000;24:164-71.
30. McKetin R, Mattick R. Attention and memory in illicit amphetamine users: comparison with non-drug-using controls. Drug Alcohol Depend 1998;50:181-4.
31. Fox H, Parrott A, Turner J. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. J Psychopharmacol 2001;15:273-81.
32. O'Reilly M, Cunningham C, Lawlor B, Walsh C, Rowan M. The effect of the menstrual cycle on electrophysiological and behavioural measures of memory and mood. Psychophysiology 2004;41:592-603.
33. Rosenberg L, Park S. Verbal and spatial functions across the menstrual cycle in healthy young women. Psychoneuroendocrinology 2002;27:835-41.
34. Sobell L, Sobell M. Timeline Follow-back: a technique for assessing self-reported alcohol consumption. In: Litten R, Allen J, eds. Measuring alcohol consumption. New Jersey: The Humana Press Inc, 1992:41-72.
35. The Psychological Corporation. WASI: Wechsler Abbreviated Scale of Intelligence. San Antonio: Harcourt Brace & Company, 1999.
36. Wechsler D. Wechsler Intelligence Scale for Children. 3rd ed. San Antonio, TX: The Psychological Corporation, 1991.
37. Wechsler D. Wechsler Adult Intelligence Scale. 3rd ed. San Antonio, TX: The Psychological Corporation, 1997.
38. Sahakian B, Owen A. Computerized assessment in neuropsychiatry using CANTAB: Discussion paper. J Roy Soc Med 1992;85:399-402.
39. Rey A. L'Examen Clinique en Psychologie. Paris: Press Universitaire de France, 1964.
40. Smith A. Symbol Digit Modalities Test Revised. Los Angeles, CA: Western Psychological Services, 1982.
41. Beck A, Steer R, Brown G. Beck Depression Inventory-Second Edition Manual. San Antonio: The Psychological Corporation, 1996.
42. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
43. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington DC: APA, 1994.
44. First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician Version. Washington, DC: American Psychiatric Association, 1997.
45. Lezak M. Neuropsychological assessment. 3rd ed. Oxford: Oxford University Press, 1995.
46. Pope Jr HG, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend 2003;69:303-10.
47. Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL. Dose-related neurocognitive effects of marijuana use. Neurology 2002;59:1337-43.
48. Ehrenreich H, Rinn T, Kunert HJ, Moeller MR, Poser W, Schilling L, et al. Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology 1999;142:295-301.
49. Kempel P, Lampe K, Parnefjord R, Hennig J, Kunert HJ. Auditory-evoked potentials and selective attention: different ways of information processing in cannabis users and controls. Neuropsychobiology 2003;48:95-101.
50. Jacobsen LK, Mencl WE, Westerveld M, Pugh KR. Impact of cannabis use on brain function in adolescents. Ann NY Acad Sci 2004;1021:384-90.
51. Fried PA, Watkinson B, Gray R. Neurocognitive consequences of marihuana - a comparison with pre-drug performance. Neurotoxicol Teratol 2005;27:231-9.